{
    "organizations": [],
    "uuid": "9d39676cd2f3a749d9ad9e335c612ee232b712ea",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-new-data-reinforce-positive-impact/brief-new-data-reinforce-positive-impact-of-the-oncotype-dx-genomic-prostate-score-test-in-guiding-treatment-decisions-idUSFWN1SS0FT",
    "ord_in_thread": 0,
    "title": "BRIEF-New Data Reinforce Positive Impact Of The Oncotype Dx Genomic Prostate Score Test In Guiding Treatment Decisions",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 21 (Reuters) - Genomic Health Inc:\n* NEW DATA REINFORCE POSITIVE IMPACT OF THE ONCOTYPE DX® GENOMIC PROSTATE SCORE™ TEST IN GUIDING TREATMENT DECISIONS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-21T20:18:00.000+03:00",
    "crawled": "2018-05-22T19:25:16.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "genomic",
        "health",
        "inc",
        "new",
        "data",
        "reinforce",
        "positive",
        "impact",
        "oncotype",
        "genomic",
        "prostate",
        "test",
        "guiding",
        "treatment",
        "decision",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}